EBITDA Summary of Baotou Dongbao Bio-Tech Co.,Ltd

Baotou Dongbao Bio-Tech Co.,Ltd's latest annual EBITDA in 2023 was 236.24 Million CNY , up 3.73% from previous year.
Baotou Dongbao Bio-Tech Co.,Ltd's latest quarterly EBITDA in 2024 Q2 was 31.98 Million CNY , down -43.1% from previous quarter.
Baotou Dongbao Bio-Tech Co.,Ltd reported an annual EBITDA of 225.19 Million CNY in 2022, up 124.59% from previous year.
Baotou Dongbao Bio-Tech Co.,Ltd reported an annual EBITDA of 103.69 Million CNY in 2021, up 34.6% from previous year.
Baotou Dongbao Bio-Tech Co.,Ltd reported a quarterly EBITDA of 31.98 Million CNY for 2024 Q2, down -43.1% from previous quarter.
Baotou Dongbao Bio-Tech Co.,Ltd reported a quarterly EBITDA of 39.26 Million CNY for 2023 Q3, down -6.96% from previous quarter.

Annual EBITDA Chart of Baotou Dongbao Bio-Tech Co.,Ltd (2023 - 2008)

Historical Annual EBITDA of Baotou Dongbao Bio-Tech Co.,Ltd (2023 - 2008)

Year	EBITDA	EBITDA Growth
2023	236.24 Million CNY	3.73%
2022	225.19 Million CNY	124.59%
2021	103.69 Million CNY	34.6%
2020	75.14 Million CNY	-2.5%
2019	73.24 Million CNY	-4.42%
2018	78.78 Million CNY	42.13%
2017	53.61 Million CNY	30.66%
2016	40.83 Million CNY	30.6%
2015	34.01 Million CNY	6.42%
2014	32.45 Million CNY	-59.36%
2013	74.7 Million CNY	29.39%
2012	57.3 Million CNY	47.18%
2011	40.01 Million CNY	7.23%
2010	33.22 Million CNY	48.81%
2009	20.38 Million CNY	9.74%
2008	18.91 Million CNY	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	33.43 Million CNY	17.22%
2024 Q2	31.98 Million CNY	-43.1%
2023 Q3	39.26 Million CNY	-6.96%
2023 Q4	29.22 Million CNY	-25.56%
2023 FY	- CNY	3.73%
2023 Q2	42.19 Million CNY	-0.38%
2023 Q1	42.35 Million CNY	54.54%
2022 Q3	37.66 Million CNY	-16.94%
2022 FY	- CNY	124.59%
2022 Q4	27.41 Million CNY	-27.22%
2022 Q2	45.34 Million CNY	48.04%
2022 Q1	30.62 Million CNY	17.34%
2021 Q2	5.18 Million CNY	-17.1%
2021 Q1	6.25 Million CNY	-38.09%
2021 Q4	26.1 Million CNY	225.59%
2021 FY	- CNY	34.6%
2021 Q3	8.01 Million CNY	54.66%
2020 Q2	3.79 Million CNY	-24.89%
2020 FY	- CNY	-2.5%
2020 Q4	10.1 Million CNY	38.26%
2020 Q1	5.05 Million CNY	-55.86%
2020 Q3	7.3 Million CNY	92.58%
2019 Q4	11.44 Million CNY	49.21%
2019 FY	- CNY	-4.42%
2019 Q1	9.18 Million CNY	-33.05%
2019 Q2	13.21 Million CNY	43.79%
2019 Q3	7.66 Million CNY	-41.97%
2018 Q2	12.58 Million CNY	25.6%
2018 Q4	13.72 Million CNY	71.38%
2018 FY	- CNY	42.13%
2018 Q3	8 Million CNY	-36.36%
2018 Q1	10.01 Million CNY	-2.75%
2017 Q3	4.16 Million CNY	-51.58%
2017 FY	- CNY	30.66%
2017 Q1	6.56 Million CNY	-61.4%
2017 Q2	8.59 Million CNY	30.94%
2017 Q4	10.3 Million CNY	147.45%
2016 Q4	17.01 Million CNY	598.91%
2016 FY	- CNY	30.6%
2016 Q2	8.78 Million CNY	581.08%
2016 Q1	1.29 Million CNY	-73.09%
2016 Q3	2.43 Million CNY	-72.3%
2015 Q1	4.07 Million CNY	-46.96%
2015 Q4	4.79 Million CNY	8.3%
2015 Q3	4.42 Million CNY	-25.17%
2015 Q2	5.91 Million CNY	45.04%
2015 FY	- CNY	6.42%
2014 Q3	-227.46 Thousand CNY	-103.69%
2014 Q2	6.16 Million CNY	13.21%
2014 Q1	5.44 Million CNY	-70.51%
2014 FY	- CNY	-59.36%
2014 Q4	7.69 Million CNY	3481.42%
2013 Q1	19.01 Million CNY	-14.02%
2013 Q4	18.45 Million CNY	41.15%
2013 Q3	13.07 Million CNY	-21.37%
2013 Q2	16.63 Million CNY	-12.55%
2013 FY	- CNY	29.39%
2012 FY	- CNY	47.18%
2012 Q2	8.61 Million CNY	16.63%
2012 Q3	11.61 Million CNY	34.81%
2012 Q4	22.11 Million CNY	90.36%
2012 Q1	7.38 Million CNY	-39.36%
2011 Q3	4.05 Million CNY	-61.12%
2011 Q4	12.18 Million CNY	200.54%
2011 Q2	10.42 Million CNY	53.7%
2011 Q1	6.78 Million CNY	-29.39%
2011 FY	- CNY	7.23%
2010 Q1	5.63 Million CNY	0.0%
2010 Q3	4.9 Million CNY	-52.04%
2010 Q2	10.21 Million CNY	81.47%
2010 FY	- CNY	48.81%
2010 Q4	9.6 Million CNY	96.08%
2009 FY	- CNY	9.74%
2008 FY	- CNY	0.0%

Peer EBITDA Comparison of Baotou Dongbao Bio-Tech Co.,Ltd

Name	EBITDA	EBITDA Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	-141.51 Million CNY	266.944%
Anhui Fengyuan Pharmaceutical Co., Ltd.	388.66 Million CNY	39.217%
Dong-E-E-Jiao Co.,Ltd.	1.53 Billion CNY	84.654%
Livzon Pharmaceutical Group Inc.	3.29 Billion CNY	92.836%
Hainan Haiyao Co., Ltd.	152.19 Million CNY	-55.223%
Tus-Pharmaceutical Group Co., Ltd.	62.18 Million CNY	-279.919%
Jilin Aodong Pharmaceutical Group Co., Ltd.	1.87 Billion CNY	87.423%
Changchun High-Tech Industries (Group) Inc.	6.09 Billion CNY	96.124%
Apeloa Pharmaceutical Co.,Ltd	1.79 Billion CNY	86.816%
PKU HealthCare Corp.,Ltd.	132.39 Million CNY	-78.443%
Chengdu Huasun Technology Group Inc., Ltd.	74.04 Million CNY	-219.056%
Dezhan Healthcare Company Limited	219.36 Million CNY	-7.697%
Jinling Pharmaceutical Company Limited	249.63 Million CNY	5.362%
Jiuzhitang Co., Ltd.	460.28 Million CNY	48.674%
Huapont Life Sciences Co., Ltd.	2.12 Billion CNY	88.895%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	945.42 Million CNY	75.012%
Shandong Wohua Pharmaceutical Co., Ltd.	87.98 Million CNY	-168.491%
Hengkang Medical Group Co., Ltd.	348.09 Million CNY	32.132%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	453.78 Million CNY	47.939%
Qianjiang Yongan Pharmaceutical Co., Ltd.	141.6 Million CNY	-66.83%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	124.71 Million CNY	-89.421%
Jinhe Biotechnology CO., LTD.	345.42 Million CNY	31.607%
Teyi Pharmaceutical Group Co.,Ltd	369.46 Million CNY	36.057%
Kunming Longjin Pharmaceutical Co., Ltd.	-31.19 Million CNY	857.25%
Beijing Aosaikang Pharmaceutical Co., Ltd.	-112.74 Million CNY	309.537%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	1.38 Billion CNY	82.988%
Anhui Huangshan Capsule Co., Ltd.	118.18 Million CNY	-99.889%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	166.4 Million CNY	-41.967%
Zhuhai Rundu Pharmaceutical Co., Ltd.	215.02 Million CNY	-9.869%
Huaren Pharmaceutical Co., Ltd.	431.65 Million CNY	45.27%
Tianjin Ringpu Bio-Technology Co.,Ltd.	711.43 Million CNY	66.793%
Shanxi Zhendong Pharmaceutical Co.,Ltd	94.75 Million CNY	-149.325%
Fuan Pharmaceutical (Group) Co., Ltd.	528.99 Million CNY	55.34%
Hybio Pharmaceutical Co., Ltd.	-233.61 Million CNY	201.125%
Hunan Er-Kang Pharmaceutical Co., Ltd	12.02 Million CNY	-1865.031%
Changjiang Pharmaceutical Group Co., Ltd.	-572.69 Million CNY	141.251%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	383.11 Million CNY	38.336%
Fujian Cosunter Pharmaceutical Co., Ltd.	-190.85 Million CNY	223.78%
Beijing Science Sun Pharmaceutical Co., Ltd.	7.7 Million CNY	-2966.907%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	87.94 Million CNY	-168.613%
Hainan Poly Pharm. Co., Ltd	309.33 Million CNY	23.629%
Jiangxi Synergy Pharmaceutical Co., Ltd.	192.54 Million CNY	-22.698%
Wuhan Hiteck Biological Pharma Co.,Ltd	-73.65 Million CNY	420.735%
Shandong Xinhua Pharmaceutical Company Limited	1.09 Billion CNY	78.437%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	435.22 Million CNY	45.719%
PharmaBlock Sciences (Nanjing), Inc.	380.8 Million CNY	37.962%
Jinghua Pharmaceutical Group Co., Ltd.	417.61 Million CNY	43.429%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	-43.99 Million CNY	636.994%
Betta Pharmaceuticals Co., Ltd.	696.09 Million CNY	66.061%
Tibet AIM Pharm. Inc.	50.76 Million CNY	-365.397%
Shenzhen Kangtai Biological Products Co., Ltd.	1.29 Billion CNY	81.759%
Shandong Shanda Wit Science and Technology Co., Ltd.	1.39 Billion CNY	83.112%
Pacific Shuanglin Bio-pharmacy Co., LTD	841.98 Million CNY	71.942%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	300.14 Million CNY	21.289%
Xiamen Kingdomway Group Company	588.78 Million CNY	59.876%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	127.06 Million CNY	-85.925%
Walvax Biotechnology Co., Ltd.	938.22 Million CNY	74.82%
Sunflower Pharmaceutical Group Co.,Ltd	1.54 Billion CNY	84.728%
Harbin Gloria Pharmaceuticals Co., Ltd	275.28 Million CNY	14.182%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	4.68 Billion CNY	94.961%
Hunan Hansen Pharmaceutical Co., Ltd.	280.66 Million CNY	15.826%
Changzhou Qianhong Biopharma CO.,LTD	278.66 Million CNY	15.224%
Shenzhen Weiguang Biological Products Co., Ltd.	350.21 Million CNY	32.542%
Honz Pharmaceutical Co., Ltd.	133.53 Million CNY	-76.919%
Northeast Pharmaceutical Group Co., Ltd.	1.19 Billion CNY	80.255%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	217.47 Million CNY	-8.631%
Guizhou Xinbang Pharmaceutical Co., Ltd.	654.01 Million CNY	63.878%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	477.37 Million CNY	50.512%
Zhejiang Yatai Pharmaceutical Co., Ltd.	76.31 Million CNY	-209.572%
Zhejiang NHU Company Ltd.	5.24 Billion CNY	95.498%
ApicHope Pharmaceutical Co., Ltd	464.04 Million CNY	49.09%
Shanghai Kaibao Pharmaceutical CO.,Ltd	375.33 Million CNY	37.057%
Beijing SL Pharmaceutical Co., Ltd.	610.29 Million CNY	61.29%
Yunnan Baiyao Group Co.,Ltd	5.2 Billion CNY	95.463%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	127.72 Million CNY	-84.971%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	228.9 Million CNY	-3.208%
Guangdong Lifestrong Pharmacy Co., Ltd.	50.95 Million CNY	-363.59%
Huadong Medicine Co., Ltd	4.61 Billion CNY	94.883%
Jiangsu Nhwa Pharmaceutical Co., LTD	1.33 Billion CNY	82.357%
Harbin Medisan Pharmaceutical Co., Ltd.	183.66 Million CNY	-28.629%
LanZhou Foci Pharmaceutical Co.,Ltd.	135.36 Million CNY	-74.519%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	1.04 Billion CNY	77.436%
Beijing Beilu Pharmaceutical Co., Ltd	36.44 Million CNY	-548.213%
Nanjing Hicin Pharmaceutical Co., Ltd.	97 Million CNY	-143.548%
Renhe Pharmacy Co., Ltd.	1.05 Billion CNY	77.515%
Chongqing Pharscin Pharmaceutical Co., Ltd.	125.84 Million CNY	-87.722%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	863.95 Million CNY	72.656%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	-320.08 Million CNY	173.806%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	-298.6 Million CNY	179.115%

Global Stocks Search

Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ)

EBITDA Summary of Baotou Dongbao Bio-Tech Co.,Ltd

Annual EBITDA Chart of Baotou Dongbao Bio-Tech Co.,Ltd (2023 - 2008)

Historical Annual EBITDA of Baotou Dongbao Bio-Tech Co.,Ltd (2023 - 2008)

Peer EBITDA Comparison of Baotou Dongbao Bio-Tech Co.,Ltd